Luca Benatti
At a glance: Luca Benatti is Director at Quince Therapeutics (QNCX). Their latest SEC Form 4, filed Dec 29, 2025, reported a sale of $35.6M. On file: 0 purchase lines ($0) and 1 sale line ($35.6M).
Disclosed holdings: about $1.6M of QNCX stock: 39,179 shares reported on their latest Form 4 (filed Dec 29, 2025), valued at the Nov 18, 2026 close of $40.59. This counts only QNCX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Quince Therapeutics, Inc. (QNCX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 29SEC | QNCXQuince Therapeutics, Inc. | Sell | 50,00039,179 held (−56%) | $712.00 | $35.6M | -94.3% |
- Sell
Director Luca Benatti sold $35.6M of QNCX at $712.00 — cuts the stake by 56%.
Follow Luca Benatti
Get one email when Luca Benatti files a new purchase or sale. Free.
At most one email a day about Luca Benatti, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.